headaches, altered mental status (AMS), weight loss or high-dose corticosteroids. 6, [11] [12] [13] However, the clinical presentation of cryptococcosis in immunocompromised patients is often atypical, overlaps with other medical conditions and in low-prevalence locations results in a delayed diagnosis. This delay often leads to an increased risk of neurological sequela. 14 
| PATIENTS/METHODS

| Ethics statement
The present investigation is in health insurance portability and ac- 
| Patients and data collection
We collected data on all patients with a culture that grew
Cryptococcus or with positive serum antigens detected from any specimen (pleural, CSF, blood, synovial, bronchoalveolar lavage, peritoneal fluid and tissue) that were recorded at the University of Colorado Hospital microbiology laboratory between January 2000
and February 2017. After collecting all negative serum cryptococcal antigen results from the microbiology laboratory during the same period, controls were randomly chosen patients from this group and matched to cases by specimen collection date, age and gender at a 1:2 (case: control) ratio. 
| Definitions
A detailed description of the definition of each variable is already published. 15 For a direct access, please see Appendix A.
| Statistical analysis:
We used data from 167 patients which included 55 patients with 
| RESULTS
| Clinical characteristics of patients with cryptococcosis
We evaluated a total of 55 patients with Cryptococcus infection and 112 controls without infection ( Approximately 15% of patients had meningeal enhancement on the MRI result. As reported previously, our data confirm the lack of systemic response, lack of meningeal enhancement on MRI images in most of the cases and possible SIADH-related hyponatremia in case patients.
| Predictors of cryptococcal infection
In a multivariable analysis, the following variables were found to be statistically significantly associated with cryptococcosis at the 0.05 alpha level ( 
| Predictors of cryptococcal meningitis disease
In a multivariable analysis, the following variables were found to be statistically significantly associated with cryptococcal meningitis at the 0.05 alpha level ( 
| Outcomes and adverse clinical outcomes in cryptococcal meningitis
Cryptococcal meningitis resulted in hearing impairment (16% vs 4%, P = .013), muscle weakness (40 vs 20%, P = .021), cognitive deficits (33% vs 6%, P = .0001) or any adverse outcome (84% vs 29%, P = .0001) more frequently than controls (Figure 1 ). Hydrocephalus with the need for a ventriculoperitoneal shunt (7.4%) and death (28.1%) was frequent in this cohort of patients with cryptococcal meningitis. Relapses occurred in 23% of the cases. Stroke arose as a complication in 33% of the patients with cryptococcal meningitis.
| DISCUSSION
We uncovered clinical symptoms such as headaches, respiratory complaints, history of pulmonary disease and corticosteroids as strong predictors of cryptococcosis in a low-prevalence tertiary care US medical centre. These factors applied to our cohort of patients with a significant proportion of immunocompromised conditions such as HIV infection, malignancy or transplantation.
Furthermore, hypoglycorrhachia, increased CSF protein and corticosteroids use at presentation were associated with increased likelihood of cryptococcal meningitis compared to controls. Patients with cryptococcosis often present with non-specific symptomsas shown here-and they do not display a systemic inflammatory response. Therefore, the above predictors may be useful tools to identify patients with failure to thrive or subacute symptoms who have cryptococcosis. We also described severe adverse outcomes in survivors with cryptococcal meningitis. These meningitis survivors are more likely to develop hearing impairment, muscle weakness and cognitive deficits compared to other conditions that cause altered mental status. Previous cohorts have shown rates up to 45% of long-term neurological deficits following cryptococcal meningitis, which included cognitive impairment, vision loss, ataxia, deafness and seizures. 14 Strokes-seen at a high rate in our cohort-are a complication of cryptococcal meningitis-associated vasculopathy and are rarely described. 16 Strokes in this setting affect the basal ganglia and are a component of secondary neurological deficits.
Limited research currently exists on predictive factors of cryptococcal meningitis in North America, and specifically in the Mountain West Region. This study confirmed previously recognised common risk factors for cryptococcosis: organ transplant, HIV infection, corticosteroid use and malignancy. In contrast to previous studies, the presence of fever, 6,11 altered mental status 17 or constitutional symptoms were unpredictive of cryptococcosis or meningitis in our cohort.
We also did not observe other host-related factors that have been previously reported like smoking, diabetes and ethnicity [18] [19] [20] [21] with
Cryptococcus infection. This may describe a true absence of these associations or associations may have been missed due to small sample size. F I G U R E 1 Adverse clinical outcomes for patients with cryptococcal meningitis vs controls. VPS, ventriculoperitoneal shunt. *P-value <.05; **P-value <.005
T A B L E 2 Multivariable analysis for cryptococcal infection predictors
We are unfamiliar with potential protective clinical factors that reduce the risk of cryptococcal infection. Some studies have suggested a protective role for calcineurin inhibitors (CNI) for CNS invasion in solid organ transplant recipients, 22 and some in vitro data demonstrated CNI antifungal activity. 23, 24 In our cohort, we did not observe a pro- A larger prospective study can confirm and refine our findings.
Factors associated with a reduced risk of infection, such as hypertension and monocytosis deserve further follow-up studies. Cryptococcal infection is the third most common invasive fungal infection among immunocompromised hosts. 27 It leads to significant mortality and disabling neurological sequelae. Clinical tools to improve the timely recognition of the infection will likely result in early diagnosis and treatment and improved outcomes. Blood cultures were processed using the BD BACTEC 9240 automated culturing system. CD4 count, viral load and laboratory data were obtained at the time of diagnosis with the cryptococcal infection. IRS was defined per previous published guided criteria [13] . 
